These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 35319407)
1. Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms. Tariq R Curr Rev Clin Exp Pharmacol; 2023; 18(2):94-109. PubMed ID: 35319407 [TBL] [Abstract][Full Text] [Related]
2. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717 [TBL] [Abstract][Full Text] [Related]
3. Human behavioral pharmacology of psychedelics. Strickland JC; Johnson MW Adv Pharmacol; 2022; 93():105-132. PubMed ID: 35341564 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic Applications of Classic Hallucinogens. Bogenschutz MP; Ross S Curr Top Behav Neurosci; 2018; 36():361-391. PubMed ID: 28512684 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of psychedelics in psychiatry, a systematic review of the literature]. Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297 [TBL] [Abstract][Full Text] [Related]
6. LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model. Wießner I; Falchi M; Palhano-Fontes F; Feilding A; Ribeiro S; Tófoli LF Psychol Med; 2023 Mar; 53(4):1151-1165. PubMed ID: 34253268 [TBL] [Abstract][Full Text] [Related]
7. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Johnson MW; Hendricks PS; Barrett FS; Griffiths RR Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880 [TBL] [Abstract][Full Text] [Related]
8. Psychedelic drugs for psychiatric disorders. da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696 [TBL] [Abstract][Full Text] [Related]
10. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460 [TBL] [Abstract][Full Text] [Related]
11. Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD). Nichols DE ACS Chem Neurosci; 2018 Oct; 9(10):2331-2343. PubMed ID: 29461039 [TBL] [Abstract][Full Text] [Related]
12. The History of Psychedelics in Psychiatry. Nichols DE; Walter H Pharmacopsychiatry; 2021 Jul; 54(4):151-166. PubMed ID: 33285579 [TBL] [Abstract][Full Text] [Related]
14. CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality. Gobbi G J Psychiatry Neurosci; 2024; 49(5):E301-E318. PubMed ID: 39299781 [TBL] [Abstract][Full Text] [Related]